0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artificial Intelligence in Drug Discovery Market Research Report 2026
Published Date: 2026-04-22
|
Report Code: QYRE-Auto-22N1764
Home | Market Reports
Global Artificial Intelligence in Drug Discovery Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Artificial Intelligence in Drug Discovery Market Research Report 2026

Code: QYRE-Auto-22N1764
Report
2026-04-22
Pages:176
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Artificial Intelligence in Drug Discovery Market Size

The global Artificial Intelligence in Drug Discovery market was valued at US$ 2911 million in 2025 and is anticipated to reach US$ 18520 million by 2032, at a CAGR of 30.7% from 2026 to 2032.

Artificial Intelligence in Drug Discovery Market

Artificial Intelligence in Drug Discovery Market

Artificial intelligence in medicine is the use of machine learning models to search medical data and uncover insights to help improve health outcomes and patient experiences. Thanks to recent advances in computer science and informatics, artificial intelligence (AI) is quickly becoming an integral part of modern healthcare. AI algorithms and other applications powered by AI are being used to support medical professionals in clinical settings and in ongoing research. Currently, the most common roles for AI in medical settings are clinical decision support and imaging analysis. Clinical decision support tools help providers make decisions about treatments, medications, mental health and other patient needs by providing them with quick access to information or research that's relevant to their patient. Drug discovery is often one of the longest and most costly parts of drug development. AI could help reduce the costs of developing new medicines in primarily two ways: creating better drug designs and finding promising new drug combinations. With AI, many of the big data challenges facing the life sciences industry could be overcome.
The market for artificial intelligence (AI) in drug discovery is driven by the urgent need to accelerate and reduce the cost of developing new therapeutics, as traditional drug discovery is often slow, expensive, and prone to high failure rates. AI enables rapid identification of drug candidates, predictive modeling of drug-target interactions, and optimization of clinical trial design, significantly shortening development timelines. The explosion of biomedical data, including genomics, proteomics, and real-world clinical datasets, provides a rich foundation for AI algorithms to uncover novel insights. Additionally, rising investment from pharmaceutical companies, biotech firms, and venture capital in AI-driven platforms—combined with advances in deep learning, natural language processing, and generative models—is propelling adoption. Regulatory agencies’ increasing openness to AI-assisted drug development workflows also supports the growth of this transformative sector.
This report delivers a comprehensive overview of the global Artificial Intelligence in Drug Discovery market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Artificial Intelligence in Drug Discovery. The Artificial Intelligence in Drug Discovery market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Artificial Intelligence in Drug Discovery market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Artificial Intelligence in Drug Discovery manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Artificial Intelligence in Drug Discovery Market Report

Report Metric Details
Report Name Artificial Intelligence in Drug Discovery Market
Accounted market size in 2025 US$ 2911 million
Forecasted market size in 2032 US$ 18520 million
CAGR 30.7%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Hardware
  • Software
  • Service
Segment by Application
  • Early Drug Discovery
  • Preclinical Phase
  • Clinical Phase
  • Regulatory Approval
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine, NVIDIA, XtalPi, BPGbio, Owkin, CytoReason, Deep Genomics, Cloud Pharmaceuticals, BenevolentAI, Cyclica, Verge Genomics, Valo Health, Envisagenics, Euretos, BioAge Labs, Iktos, BioSymetrics, Evaxion Biotech, Aria Pharmaceuticals, Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Artificial Intelligence in Drug Discovery companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Artificial Intelligence in Drug Discovery Market growing?

Ans: The Artificial Intelligence in Drug Discovery Market witnessing a CAGR of 30.7% during the forecast period 2026-2032.

What is the Artificial Intelligence in Drug Discovery Market size in 2032?

Ans: The Artificial Intelligence in Drug Discovery Market size in 2032 will be US$ 18520 million.

Who are the main players in the Artificial Intelligence in Drug Discovery Market report?

Ans: The main players in the Artificial Intelligence in Drug Discovery Market are IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine, NVIDIA, XtalPi, BPGbio, Owkin, CytoReason, Deep Genomics, Cloud Pharmaceuticals, BenevolentAI, Cyclica, Verge Genomics, Valo Health, Envisagenics, Euretos, BioAge Labs, Iktos, BioSymetrics, Evaxion Biotech, Aria Pharmaceuticals, Inc

What are the Application segmentation covered in the Artificial Intelligence in Drug Discovery Market report?

Ans: The Applications covered in the Artificial Intelligence in Drug Discovery Market report are Early Drug Discovery, Preclinical Phase, Clinical Phase, Regulatory Approval

What are the Type segmentation covered in the Artificial Intelligence in Drug Discovery Market report?

Ans: The Types covered in the Artificial Intelligence in Drug Discovery Market report are Hardware, Software, Service

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence in Drug Discovery Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Hardware
1.2.3 Software
1.2.4 Service
1.3 Market by Application
1.3.1 Global Artificial Intelligence in Drug Discovery Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Early Drug Discovery
1.3.3 Preclinical Phase
1.3.4 Clinical Phase
1.3.5 Regulatory Approval
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence in Drug Discovery Market Perspective (2021–2032)
2.2 Global Artificial Intelligence in Drug Discovery Growth Trends by Region
2.2.1 Global Artificial Intelligence in Drug Discovery Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Artificial Intelligence in Drug Discovery Historic Market Size by Region (2021–2026)
2.2.3 Artificial Intelligence in Drug Discovery Forecasted Market Size by Region (2027–2032)
2.3 Artificial Intelligence in Drug Discovery Market Dynamics
2.3.1 Artificial Intelligence in Drug Discovery Industry Trends
2.3.2 Artificial Intelligence in Drug Discovery Market Drivers
2.3.3 Artificial Intelligence in Drug Discovery Market Challenges
2.3.4 Artificial Intelligence in Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence in Drug Discovery Players by Revenue
3.1.1 Global Top Artificial Intelligence in Drug Discovery Players by Revenue (2021–2026)
3.1.2 Global Artificial Intelligence in Drug Discovery Revenue Market Share by Players (2021–2026)
3.2 Global Top Artificial Intelligence in Drug Discovery Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Artificial Intelligence in Drug Discovery Revenue
3.4 Global Artificial Intelligence in Drug Discovery Market Concentration Ratio
3.4.1 Global Artificial Intelligence in Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence in Drug Discovery Revenue in 2025
3.5 Global Key Players of Artificial Intelligence in Drug Discovery Head Offices and Areas Served
3.6 Global Key Players of Artificial Intelligence in Drug Discovery, Products and Applications
3.7 Global Key Players of Artificial Intelligence in Drug Discovery, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Artificial Intelligence in Drug Discovery Breakdown Data by Type
4.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Type (2021–2026)
4.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Type (2027–2032)
5 Artificial Intelligence in Drug Discovery Breakdown Data by Application
5.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Application (2021–2026)
5.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Artificial Intelligence in Drug Discovery Market Size (2021–2032)
6.2 North America Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Artificial Intelligence in Drug Discovery Market Size by Country (2021–2026)
6.4 North America Artificial Intelligence in Drug Discovery Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence in Drug Discovery Market Size (2021–2032)
7.2 Europe Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Artificial Intelligence in Drug Discovery Market Size by Country (2021–2026)
7.4 Europe Artificial Intelligence in Drug Discovery Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size (2021–2032)
8.2 Asia-Pacific Artificial Intelligence in Drug Discovery Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region (2021–2026)
8.4 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Artificial Intelligence in Drug Discovery Market Size (2021–2032)
9.2 Latin America Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Artificial Intelligence in Drug Discovery Market Size by Country (2021–2026)
9.4 Latin America Artificial Intelligence in Drug Discovery Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size (2021–2032)
10.2 Middle East & Africa Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size by Country (2021–2026)
10.4 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Details
11.1.2 IBM Business Overview
11.1.3 IBM Artificial Intelligence in Drug Discovery Introduction
11.1.4 IBM Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.1.5 IBM Recent Development
11.2 Exscientia
11.2.1 Exscientia Company Details
11.2.2 Exscientia Business Overview
11.2.3 Exscientia Artificial Intelligence in Drug Discovery Introduction
11.2.4 Exscientia Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.2.5 Exscientia Recent Development
11.3 Google(Alphabet)
11.3.1 Google(Alphabet) Company Details
11.3.2 Google(Alphabet) Business Overview
11.3.3 Google(Alphabet) Artificial Intelligence in Drug Discovery Introduction
11.3.4 Google(Alphabet) Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.3.5 Google(Alphabet) Recent Development
11.4 Microsoft
11.4.1 Microsoft Company Details
11.4.2 Microsoft Business Overview
11.4.3 Microsoft Artificial Intelligence in Drug Discovery Introduction
11.4.4 Microsoft Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.4.5 Microsoft Recent Development
11.5 Atomwise
11.5.1 Atomwise Company Details
11.5.2 Atomwise Business Overview
11.5.3 Atomwise Artificial Intelligence in Drug Discovery Introduction
11.5.4 Atomwise Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.5.5 Atomwise Recent Development
11.6 Schrodinger
11.6.1 Schrodinger Company Details
11.6.2 Schrodinger Business Overview
11.6.3 Schrodinger Artificial Intelligence in Drug Discovery Introduction
11.6.4 Schrodinger Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.6.5 Schrodinger Recent Development
11.7 Aitia
11.7.1 Aitia Company Details
11.7.2 Aitia Business Overview
11.7.3 Aitia Artificial Intelligence in Drug Discovery Introduction
11.7.4 Aitia Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.7.5 Aitia Recent Development
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Details
11.8.2 Insilico Medicine Business Overview
11.8.3 Insilico Medicine Artificial Intelligence in Drug Discovery Introduction
11.8.4 Insilico Medicine Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.8.5 Insilico Medicine Recent Development
11.9 NVIDIA
11.9.1 NVIDIA Company Details
11.9.2 NVIDIA Business Overview
11.9.3 NVIDIA Artificial Intelligence in Drug Discovery Introduction
11.9.4 NVIDIA Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.9.5 NVIDIA Recent Development
11.10 XtalPi
11.10.1 XtalPi Company Details
11.10.2 XtalPi Business Overview
11.10.3 XtalPi Artificial Intelligence in Drug Discovery Introduction
11.10.4 XtalPi Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.10.5 XtalPi Recent Development
11.11 BPGbio
11.11.1 BPGbio Company Details
11.11.2 BPGbio Business Overview
11.11.3 BPGbio Artificial Intelligence in Drug Discovery Introduction
11.11.4 BPGbio Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.11.5 BPGbio Recent Development
11.12 Owkin
11.12.1 Owkin Company Details
11.12.2 Owkin Business Overview
11.12.3 Owkin Artificial Intelligence in Drug Discovery Introduction
11.12.4 Owkin Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.12.5 Owkin Recent Development
11.13 CytoReason
11.13.1 CytoReason Company Details
11.13.2 CytoReason Business Overview
11.13.3 CytoReason Artificial Intelligence in Drug Discovery Introduction
11.13.4 CytoReason Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.13.5 CytoReason Recent Development
11.14 Deep Genomics
11.14.1 Deep Genomics Company Details
11.14.2 Deep Genomics Business Overview
11.14.3 Deep Genomics Artificial Intelligence in Drug Discovery Introduction
11.14.4 Deep Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.14.5 Deep Genomics Recent Development
11.15 Cloud Pharmaceuticals
11.15.1 Cloud Pharmaceuticals Company Details
11.15.2 Cloud Pharmaceuticals Business Overview
11.15.3 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Introduction
11.15.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.15.5 Cloud Pharmaceuticals Recent Development
11.16 BenevolentAI
11.16.1 BenevolentAI Company Details
11.16.2 BenevolentAI Business Overview
11.16.3 BenevolentAI Artificial Intelligence in Drug Discovery Introduction
11.16.4 BenevolentAI Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.16.5 BenevolentAI Recent Development
11.17 Cyclica
11.17.1 Cyclica Company Details
11.17.2 Cyclica Business Overview
11.17.3 Cyclica Artificial Intelligence in Drug Discovery Introduction
11.17.4 Cyclica Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.17.5 Cyclica Recent Development
11.18 Verge Genomics
11.18.1 Verge Genomics Company Details
11.18.2 Verge Genomics Business Overview
11.18.3 Verge Genomics Artificial Intelligence in Drug Discovery Introduction
11.18.4 Verge Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.18.5 Verge Genomics Recent Development
11.19 Valo Health
11.19.1 Valo Health Company Details
11.19.2 Valo Health Business Overview
11.19.3 Valo Health Artificial Intelligence in Drug Discovery Introduction
11.19.4 Valo Health Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.19.5 Valo Health Recent Development
11.20 Envisagenics
11.20.1 Envisagenics Company Details
11.20.2 Envisagenics Business Overview
11.20.3 Envisagenics Artificial Intelligence in Drug Discovery Introduction
11.20.4 Envisagenics Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.20.5 Envisagenics Recent Development
11.21 Euretos
11.21.1 Euretos Company Details
11.21.2 Euretos Business Overview
11.21.3 Euretos Artificial Intelligence in Drug Discovery Introduction
11.21.4 Euretos Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.21.5 Euretos Recent Development
11.22 BioAge Labs
11.22.1 BioAge Labs Company Details
11.22.2 BioAge Labs Business Overview
11.22.3 BioAge Labs Artificial Intelligence in Drug Discovery Introduction
11.22.4 BioAge Labs Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.22.5 BioAge Labs Recent Development
11.23 Iktos
11.23.1 Iktos Company Details
11.23.2 Iktos Business Overview
11.23.3 Iktos Artificial Intelligence in Drug Discovery Introduction
11.23.4 Iktos Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.23.5 Iktos Recent Development
11.24 BioSymetrics
11.24.1 BioSymetrics Company Details
11.24.2 BioSymetrics Business Overview
11.24.3 BioSymetrics Artificial Intelligence in Drug Discovery Introduction
11.24.4 BioSymetrics Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.24.5 BioSymetrics Recent Development
11.25 Evaxion Biotech
11.25.1 Evaxion Biotech Company Details
11.25.2 Evaxion Biotech Business Overview
11.25.3 Evaxion Biotech Artificial Intelligence in Drug Discovery Introduction
11.25.4 Evaxion Biotech Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.25.5 Evaxion Biotech Recent Development
11.26 Aria Pharmaceuticals, Inc
11.26.1 Aria Pharmaceuticals, Inc Company Details
11.26.2 Aria Pharmaceuticals, Inc Business Overview
11.26.3 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Introduction
11.26.4 Aria Pharmaceuticals, Inc Revenue in Artificial Intelligence in Drug Discovery Business (2021–2026)
11.26.5 Aria Pharmaceuticals, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Artificial Intelligence in Drug Discovery Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Hardware
 Table 3. Key Players of Software
 Table 4. Key Players of Service
 Table 5. Global Artificial Intelligence in Drug Discovery Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Artificial Intelligence in Drug Discovery Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Artificial Intelligence in Drug Discovery Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Artificial Intelligence in Drug Discovery Market Share by Region (2021–2026)
 Table 9. Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Artificial Intelligence in Drug Discovery Market Share by Region (2027–2032)
 Table 11. Artificial Intelligence in Drug Discovery Market Trends
 Table 12. Artificial Intelligence in Drug Discovery Market Drivers
 Table 13. Artificial Intelligence in Drug Discovery Market Challenges
 Table 14. Artificial Intelligence in Drug Discovery Market Restraints
 Table 15. Global Artificial Intelligence in Drug Discovery Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Artificial Intelligence in Drug Discovery Market Share by Players (2021–2026)
 Table 17. Global Top Artificial Intelligence in Drug Discovery Players by Tier (Tier 1, Tier 2, and Tier 3), based on Artificial Intelligence in Drug Discovery Revenue, 2025
 Table 18. Ranking of Global Top Artificial Intelligence in Drug Discovery Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Artificial Intelligence in Drug Discovery Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Artificial Intelligence in Drug Discovery, Headquarters and Area Served
 Table 21. Global Key Players of Artificial Intelligence in Drug Discovery, Products and Applications
 Table 22. Global Key Players of Artificial Intelligence in Drug Discovery, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Artificial Intelligence in Drug Discovery Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Type (2021–2026)
 Table 26. Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Type (2027–2032)
 Table 28. Global Artificial Intelligence in Drug Discovery Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Application (2021–2026)
 Table 30. Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Application (2027–2032)
 Table 32. North America Artificial Intelligence in Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Artificial Intelligence in Drug Discovery Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Artificial Intelligence in Drug Discovery Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Artificial Intelligence in Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Artificial Intelligence in Drug Discovery Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Artificial Intelligence in Drug Discovery Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Artificial Intelligence in Drug Discovery Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Artificial Intelligence in Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Artificial Intelligence in Drug Discovery Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Artificial Intelligence in Drug Discovery Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Artificial Intelligence in Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Artificial Intelligence in Drug Discovery Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Artificial Intelligence in Drug Discovery Market Size by Country (US$ Million), 2027–2032
 Table 47. IBM Company Details
 Table 48. IBM Business Overview
 Table 49. IBM Artificial Intelligence in Drug Discovery Product
 Table 50. IBM Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 51. IBM Recent Development
 Table 52. Exscientia Company Details
 Table 53. Exscientia Business Overview
 Table 54. Exscientia Artificial Intelligence in Drug Discovery Product
 Table 55. Exscientia Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 56. Exscientia Recent Development
 Table 57. Google(Alphabet) Company Details
 Table 58. Google(Alphabet) Business Overview
 Table 59. Google(Alphabet) Artificial Intelligence in Drug Discovery Product
 Table 60. Google(Alphabet) Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 61. Google(Alphabet) Recent Development
 Table 62. Microsoft Company Details
 Table 63. Microsoft Business Overview
 Table 64. Microsoft Artificial Intelligence in Drug Discovery Product
 Table 65. Microsoft Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 66. Microsoft Recent Development
 Table 67. Atomwise Company Details
 Table 68. Atomwise Business Overview
 Table 69. Atomwise Artificial Intelligence in Drug Discovery Product
 Table 70. Atomwise Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 71. Atomwise Recent Development
 Table 72. Schrodinger Company Details
 Table 73. Schrodinger Business Overview
 Table 74. Schrodinger Artificial Intelligence in Drug Discovery Product
 Table 75. Schrodinger Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 76. Schrodinger Recent Development
 Table 77. Aitia Company Details
 Table 78. Aitia Business Overview
 Table 79. Aitia Artificial Intelligence in Drug Discovery Product
 Table 80. Aitia Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 81. Aitia Recent Development
 Table 82. Insilico Medicine Company Details
 Table 83. Insilico Medicine Business Overview
 Table 84. Insilico Medicine Artificial Intelligence in Drug Discovery Product
 Table 85. Insilico Medicine Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 86. Insilico Medicine Recent Development
 Table 87. NVIDIA Company Details
 Table 88. NVIDIA Business Overview
 Table 89. NVIDIA Artificial Intelligence in Drug Discovery Product
 Table 90. NVIDIA Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 91. NVIDIA Recent Development
 Table 92. XtalPi Company Details
 Table 93. XtalPi Business Overview
 Table 94. XtalPi Artificial Intelligence in Drug Discovery Product
 Table 95. XtalPi Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 96. XtalPi Recent Development
 Table 97. BPGbio Company Details
 Table 98. BPGbio Business Overview
 Table 99. BPGbio Artificial Intelligence in Drug Discovery Product
 Table 100. BPGbio Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 101. BPGbio Recent Development
 Table 102. Owkin Company Details
 Table 103. Owkin Business Overview
 Table 104. Owkin Artificial Intelligence in Drug Discovery Product
 Table 105. Owkin Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 106. Owkin Recent Development
 Table 107. CytoReason Company Details
 Table 108. CytoReason Business Overview
 Table 109. CytoReason Artificial Intelligence in Drug Discovery Product
 Table 110. CytoReason Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 111. CytoReason Recent Development
 Table 112. Deep Genomics Company Details
 Table 113. Deep Genomics Business Overview
 Table 114. Deep Genomics Artificial Intelligence in Drug Discovery Product
 Table 115. Deep Genomics Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 116. Deep Genomics Recent Development
 Table 117. Cloud Pharmaceuticals Company Details
 Table 118. Cloud Pharmaceuticals Business Overview
 Table 119. Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Product
 Table 120. Cloud Pharmaceuticals Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 121. Cloud Pharmaceuticals Recent Development
 Table 122. BenevolentAI Company Details
 Table 123. BenevolentAI Business Overview
 Table 124. BenevolentAI Artificial Intelligence in Drug Discovery Product
 Table 125. BenevolentAI Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 126. BenevolentAI Recent Development
 Table 127. Cyclica Company Details
 Table 128. Cyclica Business Overview
 Table 129. Cyclica Artificial Intelligence in Drug Discovery Product
 Table 130. Cyclica Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 131. Cyclica Recent Development
 Table 132. Verge Genomics Company Details
 Table 133. Verge Genomics Business Overview
 Table 134. Verge Genomics Artificial Intelligence in Drug Discovery Product
 Table 135. Verge Genomics Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 136. Verge Genomics Recent Development
 Table 137. Valo Health Company Details
 Table 138. Valo Health Business Overview
 Table 139. Valo Health Artificial Intelligence in Drug Discovery Product
 Table 140. Valo Health Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 141. Valo Health Recent Development
 Table 142. Envisagenics Company Details
 Table 143. Envisagenics Business Overview
 Table 144. Envisagenics Artificial Intelligence in Drug Discovery Product
 Table 145. Envisagenics Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 146. Envisagenics Recent Development
 Table 147. Euretos Company Details
 Table 148. Euretos Business Overview
 Table 149. Euretos Artificial Intelligence in Drug Discovery Product
 Table 150. Euretos Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 151. Euretos Recent Development
 Table 152. BioAge Labs Company Details
 Table 153. BioAge Labs Business Overview
 Table 154. BioAge Labs Artificial Intelligence in Drug Discovery Product
 Table 155. BioAge Labs Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 156. BioAge Labs Recent Development
 Table 157. Iktos Company Details
 Table 158. Iktos Business Overview
 Table 159. Iktos Artificial Intelligence in Drug Discovery Product
 Table 160. Iktos Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 161. Iktos Recent Development
 Table 162. BioSymetrics Company Details
 Table 163. BioSymetrics Business Overview
 Table 164. BioSymetrics Artificial Intelligence in Drug Discovery Product
 Table 165. BioSymetrics Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 166. BioSymetrics Recent Development
 Table 167. Evaxion Biotech Company Details
 Table 168. Evaxion Biotech Business Overview
 Table 169. Evaxion Biotech Artificial Intelligence in Drug Discovery Product
 Table 170. Evaxion Biotech Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 171. Evaxion Biotech Recent Development
 Table 172. Aria Pharmaceuticals, Inc Company Details
 Table 173. Aria Pharmaceuticals, Inc Business Overview
 Table 174. Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Product
 Table 175. Aria Pharmaceuticals, Inc Revenue in Artificial Intelligence in Drug Discovery Business (US$ Million), 2021–2026
 Table 176. Aria Pharmaceuticals, Inc Recent Development
 Table 177. Research Programs/Design for This Report
 Table 178. Key Data Information from Secondary Sources
 Table 179. Key Data Information from Primary Sources
 Table 180. Authors List of This Report


List of Figures
 Figure 1. Artificial Intelligence in Drug Discovery Picture
 Figure 2. Global Artificial Intelligence in Drug Discovery Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Artificial Intelligence in Drug Discovery Market Share by Type: 2025 vs 2032
 Figure 4. Hardware Features
 Figure 5. Software Features
 Figure 6. Service Features
 Figure 7. Global Artificial Intelligence in Drug Discovery Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Artificial Intelligence in Drug Discovery Market Share by Application: 2025 vs 2032
 Figure 9. Early Drug Discovery Case Studies
 Figure 10. Preclinical Phase Case Studies
 Figure 11. Clinical Phase Case Studies
 Figure 12. Regulatory Approval Case Studies
 Figure 13. Artificial Intelligence in Drug Discovery Report Years Considered
 Figure 14. Global Artificial Intelligence in Drug Discovery Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Artificial Intelligence in Drug Discovery Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Artificial Intelligence in Drug Discovery Market Share by Region: 2025 vs 2032
 Figure 17. Global Artificial Intelligence in Drug Discovery Market Share by Players in 2025
 Figure 18. Global Artificial Intelligence in Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Artificial Intelligence in Drug Discovery Revenue in 2025
 Figure 20. North America Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Artificial Intelligence in Drug Discovery Market Share by Country (2021–2032)
 Figure 22. United States Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Artificial Intelligence in Drug Discovery Market Share by Country (2021–2032)
 Figure 26. Germany Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Artificial Intelligence in Drug Discovery Market Share by Region (2021–2032)
 Figure 34. China Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Artificial Intelligence in Drug Discovery Market Share by Country (2021–2032)
 Figure 42. Mexico Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Artificial Intelligence in Drug Discovery Market Share by Country (2021–2032)
 Figure 46. Israel Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Artificial Intelligence in Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. IBM Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 50. Exscientia Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 51. Google(Alphabet) Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 52. Microsoft Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 53. Atomwise Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 54. Schrodinger Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 55. Aitia Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 56. Insilico Medicine Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 57. NVIDIA Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 58. XtalPi Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 59. BPGbio Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 60. Owkin Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 61. CytoReason Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 62. Deep Genomics Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 63. Cloud Pharmaceuticals Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 64. BenevolentAI Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 65. Cyclica Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 66. Verge Genomics Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 67. Valo Health Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 68. Envisagenics Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 69. Euretos Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 70. BioAge Labs Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 71. Iktos Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 72. BioSymetrics Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 73. Evaxion Biotech Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 74. Aria Pharmaceuticals, Inc Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021–2026)
 Figure 75. Bottom-up and Top-down Approaches for This Report
 Figure 76. Data Triangulation
 Figure 77. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS